Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Inspire Medical Systems Inc (NYSE: INSP) closed the day trading at $79.14 up 2.71% from the previous closing price of $77.05. In other words, the price has increased by $2.71 from its previous closing price. On the day, 1.72 million shares were traded. INSP stock price reached its highest trading level at $80.87 during the session, while it also had its lowest trading level at $76.915.
Ratios:
For a better understanding of INSP, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.78 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.53. For the most recent quarter (mrq), Quick Ratio is recorded 4.84 and its Current Ratio is at 6.14. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.05.
JP Morgan Downgraded its Overweight to Neutral on August 05, 2025, while the target price for the stock was maintained at $110.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on May 19 ’25 when Rondoni John sold 1,734 shares for $149.38 per share. The transaction valued at 259,025 led to the insider holds 13,766 shares of the business.
JOHN RONDONI bought 1,734 shares of INSP for $259,025 on May 19 ’25. On May 02 ’25, another insider, mcCormick Shawn, who serves as the Director of the company, sold 360 shares for $160.00 each. As a result, the insider received 57,600 and left with 24,046 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, INSP now has a Market Capitalization of 2340510208 and an Enterprise Value of 2072675328. As of this moment, Inspire’s Price-to-Earnings (P/E) ratio for their current fiscal year is 45.85, and their Forward P/E ratio for the next fiscal year is 48.11. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.72. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.72 while its Price-to-Book (P/B) ratio in mrq is 3.45. Its current Enterprise Value per Revenue stands at 2.406 whereas that against EBITDA is 39.716.
Stock Price History:
The Beta on a monthly basis for INSP is 1.20, which has changed by -0.5947565 over the last 52 weeks, in comparison to a change of 0.19554341 over the same period for the S&P500. Over the past 52 weeks, INSP has reached a high of $225.00, while it has fallen to a 52-week low of $73.92. The 50-Day Moving Average of the stock is -37.76%, while the 200-Day Moving Average is calculated to be -51.77%.
Shares Statistics:
Over the past 3-months, INSP traded about 811.82K shares per day on average, while over the past 10 days, INSP traded about 2250280 shares per day. A total of 29.57M shares are outstanding, with a floating share count of 27.91M. Insiders hold about 5.61% of the company’s shares, while institutions hold 111.18% stake in the company. Shares short for INSP as of 1752537600 were 3290632 with a Short Ratio of 4.05, compared to 1749772800 on 3398569. Therefore, it implies a Short% of Shares Outstanding of 3290632 and a Short% of Float of 15.0.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 12.0 analysts currently analyzing and rating the stock of Inspire Medical Systems Inc (INSP).The consensus estimate for the next quarter is $0.68, with high estimates of $0.84 and low estimates of $0.56.
Analysts are recommending an EPS of between $1.64 and $0.4 for the fiscal current year, implying an average EPS of $0.86. EPS for the following year is $1.57, with 14.0 analysts recommending between $2.7 and $1.11.
Revenue Estimates
16 analysts predict $221.38M in revenue for the current quarter. It ranges from a high estimate of $224.9M to a low estimate of $220M. As of the current estimate, Inspire Medical Systems Inc’s year-ago sales were $203.19MFor the next quarter, 16 analysts are estimating revenue of $264.66M. There is a high estimate of $266.7M for the next quarter, whereas the lowest estimate is $261.4M.
A total of 17 analysts have provided revenue estimates for INSP’s current fiscal year. The highest revenue estimate was $907.9M, while the lowest revenue estimate was $900M, resulting in an average revenue estimate of $904.47M. In the same quarter a year ago, actual revenue was $802.8MBased on 17 analysts’ estimates, the company’s revenue will be $1.03B in the next fiscal year. The high estimate is $1.06B and the low estimate is $1.01B.
